NotebookLM: Cast with Care
Google’s NotebookLM “deep dive” feature is taking off in popularity. I subject three of my academic papers to the deep dive treatment, and reveal its tendency to subvert content for a happier ending.
Google’s NotebookLM “deep dive” feature is taking off in popularity. I subject three of my academic papers to the deep dive treatment, and reveal its tendency to subvert content for a happier ending.
A much-publicised report suggests that white Britons’ brain tumour survival rates are lower than other ethnicities. But analysing the ethnicities categories used, and considering the diversity of the “brain tumour” label, complicates the picture, as the ‘Dismal Disease’ of Glioblastoma continues to confound.
“I think the challenge is really that we still, not only in glioblastoma, but in oncology at large, treat the majority of patients with a one-size-fits-all approach.” — Roger Stupp Blockbuster drugs are rare. To be a blockbuster, a drug must shift over $1bn worth in one year. There …